Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Critical Illness × Darbepoetin alfa × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1 Classical hematology 1

Conditions

Prostatic Neoplasms 1 Neoplasms 1 Hematologic Neoplasms 1 Fatigue 1 Critical Illness 1 Anemia 1

Interventions

Spironolactone 1 Darbepoetin alfa 1 Cholecalciferol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00381836 2015-12-04

Effect of Darbepoetin Alfa (Aranesp®) on Anemia in Patients With Advanced Hormone Independent Prostate Cancer

University of Aarhus

Phase 2/3 Terminated

Classical hematologyGenitourinary

Anemia, Fatigue, Neoplasms, Prostatic Neoplasms, Critical Illness

Data powered by HemOnc (CC BY 4.0) Colophon ⚡